GP targets drive up COPD prescribing

May 27, 2009
Sales and Marketing COPD, NHS, qof

Respiratory drugs saw the biggest growth in GP prescribing in England in 2008, thanks to new COPD targets.The rapid growth …

Almirall opens UK headquarters

May 27, 2009
Sales and Marketing Almirall

Spanish pharma company Almirall has opened its new UK and Ireland headquarters in West London's Stockley Park.The site will be …

Quotient buys Scottish clinical unit from Charles River

May 26, 2009
Research and Development Charles River, Quotient

Contract research organisation Quotient Bioresearch has acquired a facility from Charles River Laboratories that will boost its capabilities in the …

MedeConnect launches next generation of online doctor surveys

May 21, 2009
Medical Communications MedConnect

The market research arm of online doctors' community Doctors.net.uk has launched a new qualitative market research service which expands the …

Sanofi launches web TV channel

May 21, 2009
Sales and Marketing Sanofi-Aventis, digi

Sanofi-Aventis has set up an online television channel to promote its business, commitment to social responsibility and employee activities. To …

Omnicom opens new healthcare coms agency

May 21, 2009
Medical Communications TogoRun

Media giant the Omnicom Group has launched a TogoRun, a new healthcare communications agency with offices in London and New …

Phase III drug superior to Spiriva, says Novartis

May 21, 2009
Research and Development, Sales and Marketing COPD, Novarits

Novartis says its COPD treatment has shown significant benefits over two established rivals, and could form the cornerstone of a …

Pfizer signs Indian generic deals

May 21, 2009
Sales and Marketing Pfizer, generics

Pfizer has expanded its presence in the generics market with deals that see it licence 75 products from two Indian …

Mexican flu: contained but not beaten

May 21, 2009
Research and Development Mexico, Vaccine, flu, pandemic

Global efforts to limit the impact of the new strain of H1N1 flu virus have proven successful, but the threat …

ABPI looks to breathe new life into industry relations

May 20, 2009
Medical Communications, Sales and Marketing ABPI, doctors, industry relations, medical education, vita

The ABPI has unveiled a new proactive agenda which it hopes will help improve the industry’s reputation and relationships with …

Takeda to market new bone cancer drug

May 20, 2009
Research and Development, Sales and Marketing MA, Takeda

Takeda has gained the rights to the first treatment for a new malignant bone cancer affecting children and young adults. …

Cannabis-derived MS drug filed for European approval

May 20, 2009
Research and Development, Sales and Marketing GW, Sativex

Sativex, the cannabis-derived product developed by GW Pharmaceuticals, could be finally set for European approval after five years of delay. …

EFPIA plans counterfeit crackdown

May 20, 2009
Manufacturing and Production, Research and Development EFPIA, counterfeits

 European pharmaceutical industry association EFPIA has unveiled a new scheme to crack down on counterfeit medicines.Beginning with a trial run …

SkyePharma cuts staff at French and Swiss facilities

May 20, 2009
Research and Development, Sales and Marketing Skyepharma

SkyePharma has moved ahead with plans to cut its workforce at a manufacturing plant in France by a third as …

EU gives the nod to Teva/Lonza biosimilar venture

May 18, 2009
Manufacturing and Production, Sales and Marketing Lonza, Teva

The European Commission has given a green light to the formation of a joint venture company between Teva and Lonza …

The medical-marketing interface and how to bridge the gap

May 18, 2009
Research and Development, Sales and Marketing marketing, medical

Drug companies are not charities and are accountable to their shareholders, as we all know. Products have to be sold …

GSK signs oncology deal with UK biotech

May 18, 2009
Research and Development, Sales and Marketing GSK, Oxford Biotherapeutics

GSK has struck a deal with Oxford BioTherapeutics to develop therapies for primary, metastatic and recurring forms of cancer. The …

Sanofi-Aventis starts work on dengue fever plant

May 15, 2009
Manufacturing and Production Sanofi-Aventis

Sanofi-Aventis' vaccine subsidiary Sanofi Pasteur has broken ground on a 350 million euro facility devoted to the producing a vaccine …

Sanofi-Aventis signs deal with Japanese biotech

May 15, 2009
Research and Development, Sales and Marketing Sanofi-Aventis

Sanofi-Aventis has signed an early-stage research deal with biotech Kyowa Hakko Kirin, and will receive rights to its preclinical stage …

Kendle trims down as profits slump

May 15, 2009
Research and Development Kendle

Contract research organisation Kendle joined many of its peers in reporting a slump in demand for its clinical research services …

The Gateway to Local Adoption Series

Latest content